Age-Related alterations in the metabolic profile in the hippocampus of the senescence-accelerated mouse prone 8: A spontaneous Alzheimer's disease mouse model

Journal of Alzheimer's Disease

Volumn 39, Issue 4, 2014, Pages 841-848

  Wang, Hualong ^a   Lian, Kaoqi ^a   Han, Bing ^a   Wang, Yanyong ^a   Kuo, Sheng Han ^b   Geng, Yuan ^c   Qiang, Jing ^a   Sun, Meiyu ^a   Wang, Mingwei ^a,c  

^a HEBEI MEDICAL UNIVERSITY   (China)

^b Hebei Medical University ^*  (United States)

^c Brain Aging and Cognitive Neuroscience Laboratory of Hebei Province   (China)

Author keywords

Aging; Alzheimer's disease; cholesterol; gas chromatography mass spectrometry; hippocampus; metabolic profiles

Indexed keywords

4 AMINOBUTYRIC ACID; 5,8,11,14,17 ICOSAPENTAENOIC ACID; ADENOSINE PHOSPHATE; ALANINE; ASCORBIC ACID; ASPARTIC ACID; CHOLESTEROL; CITRIC ACID; CREATININE; ELAIDIC ACID; FUMARIC ACID; GLUTAMIC ACID; GLYCEROL STEARATE; GLYCEROPHOSPHOLIPID; GLYCINE; INOSITOL; INOSITOL PHOSPHATE; LACTIC ACID; MALIC ACID; N ACETYLASPARTIC ACID; OLEIC ACID; PALMITIC ACID; PHOSPHORIC ACID; PYROGLUTAMIC ACID; SERINE; STEARIC ACID; SUCCINIC ACID; THREONINE; UREA;

AGING; ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL METABOLISM; COGNITION; COGNITIVE DEFECT; CREATININE BLOOD LEVEL; HIPPOCAMPUS; LACTATE BLOOD LEVEL; MALE; MASS FRAGMENTOGRAPHY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SENESCENCE ACCELERATED MOUSE; SENESCENCE ACCELERATED MOUSE PRONE 8; UREA BLOOD LEVEL;

AGING; ALZHEIMER'S DISEASE; CHOLESTEROL; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HIPPOCAMPUS; METABOLIC PROFILES;

AGING; ALZHEIMER DISEASE; ANIMALS; DISEASE MODELS, ANIMAL; HIPPOCAMPUS; MALE; METABOLOME; MICE;

EID: 84896822801     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-131463     Document Type: Article

References (38)

1. O'Brien RJ, Wong PC (2011) Amyloid precursor protein processing and Alzheimer's disease. Annu Rev Neurosci 34, 185-204.
2. Trushina E, Nemutlu E, Zhang S, Christensen T, Camp J, Mesa J, Siddiqui A, Tamura Y, Sesaki H, Wengenack TM, Dzeja PP, Poduslo JF (2012) Defects in mitochondrial dynamics and metabolomic signatures of evolving energetic stress in mouse models of familial Alzheimer's disease. PLoS One 7, e32737.
3. Trushina E, Dutta T, Persson XM, Mielke MM, Petersen RC (2013) Identification of altered metabolic pathways in plasma and CSF in mild cognitive impairment and Alzheimer's disease using metabolomics. PLoS One 8, e63644.
4. Morley JE, Farr SA, Kumar VB, Armbrecht HJ (2012) The SAMP8 mouse: A model to develop therapeutic interventions for Alzheimer's disease. Curr Pharm Des 18, 1123-1130.
5. Morley JE, Armbrecht HJ, Farr SA, Kumar VB (2012) The senescence accelerated mouse (SAMP8) as a model for oxida-tive stress and Alzheimer's disease. Biochim Biophys Acta 1822, 650-656.
6. Han X (2005) Lipid alterations in the earliest clinically recognizable stage of Alzheimer's disease: Implication of the role of lipids in the pathogenesis of Alzheimer's disease. Curr Alzheimer Res 2, 65-77.
7. Jansen D, Janssen CI, Vanmierlo T, Dederen PJ, van Rooij D, Zinnhardt B, Nobelen CL, Janssen AL, Hafkemeijer A, Mut-saers MP, Doedee AM, Kuipers AA, Broersen LM, Mulder M, Kiliaan AJ (2012) Cholesterol and synaptic compensatory mechanisms in Alzheimer's disease mice brain during aging. J Alzheimers Dis 31, 813-826.
8. Maulik M, Westaway D, Jhamandas JH, Kar S (2013) Role of cholesterol in APP metabolism and its significance in Alzheimer's disease pathogenesis. Mol Neurobiol 47, 37-63.
9. Bubber P, Haroutunian V, Fisch G, Blass JP, Gibson GE (2005) Mitochondrial abnormalities in Alzheimer brain: Mechanistic implications. Ann Neurol 57, 695-703.
10. Yao J, Brinton RD (2012) Estrogen regulation of mito-chondrial bioenergetics: Implications for prevention of Alzheimer's disease. Adv Pharmacol 64, 327-371.
11. Ellison DW, Beal MF, Mazurek MF, Bird ED, Martin JB (1986) A postmortem study of amino acid neurotransmitters in Alzheimer's disease. Ann Neurol 20, 616-621.
12. Nilsen LH, Melo TM, Saether O, Witter MP, Sonnewald U (2012) Altered neurochemical profile in the McGill-R-Thy1-APP rat model of Alzheimer's disease: A longitudinal in vivo 1 H MRS study. J Neurochem 123, 532-541.
13. Flood JF, Morley JE (1998) Learning and memory in the SAMP8 mouse. Neurosci Biobehav Rev 22, 1-20.
14. Nomura Y, Okuma Y (1999) Age-related defects in lifespan and learning ability in SAMP8 mice. Neurobiol Aging 20, 111-115.
15. Ma Q, Qiang J, Gu P, Wang Y, Geng Y, Wang M (2011) Age-related autophagy alterations in the brain of senescence accelerated mouse prone 8 (SAMP8) mice. Exp Gerontol 46, 533-541.
16. Nicholson JK, Lindon JC (2008) Systems biology: Metabo-nomics. Nature 455, 1054-1056.
17. Koek MM, Jellema RH, van der Greef J, Tas AC, Han-kemeier T (2011) Quantitative metabolomics based on gas chromatography mass spectrometry: Status and perspectives. Metabolomics 7, 307-328.
18. Wu H, Xue R, Lu C, Deng C, Liu T, Zeng H, Wang Q, Shen X (2009) Metabolomic study for diagnostic model of oesophageal cancer using gas chromatography/mass spec-trometry. J Chromatogr B Analyt Technol Biomed Life Sci 877, 3111-3117.
19. Jonsson P, Bruce SJ, Moritz T, Trygg J, Sjostrom M, Plumb R, Granger J, Maibaum E, Nicholson JK, Holmes E, Antti H (2005) Extraction, interpretation and validation of information for comparing samples in metabolic LC/MS data sets. Analyst 130, 701-707.
20. Paban V, Fauvelle F, Alescio-Lautier B (2010) Age-related changesinmetabolic profilesofrat hippocampus and cortices. Eur J Neurosci 31, 1063-1073.
21. Zhang X, Liu H, Wu J, Liu M, Wang Y (2009) Metabonomic alterations in hippocampus, temporal and prefrontal cortex with age in rats. Neurochem Int 54, 481-487.
22. Salek RM, Xia J, Innes A, Sweatman BC, Adalbert R, Randle S, McGowan E, Emson PC, Griffin JL (2010) A metabolomic study of the CRND8 transgenic mouse model of Alzheimer's disease. Neurochem Int 56, 937-947.
23. Dietschy JM, Turley SD (2001) Cholesterol metabolism in the brain. Curr Opin Lipidol 12, 105-112.
24. Ricciarelli R, Canepa E, Marengo B, Marinari UM, Poli G, Pronzato MA, Domenicotti C (2012) Cholesterol and Alzheimer's disease: A still poorly understood correlation. IUBMB Life 64, 931-935.
25. Wang L, Schuster GU, Hultenby K, Zhang Q, Andersson S, Gustafsson JA (2002) Liver X receptors in the central nervous system: From lipid homeostasis to neuronal degeneration. Proc Natl Acad Sci USA 99, 13878-13883.
26. Kang J, Rivest S (2012) Lipid metabolism and neuroinflam-mation in Alzheimer's disease: A role for liver X receptors. Endocr Rev 33, 715-746.
27. Kurata T, Kawai H, Miyazaki K, Kozuki M, Morimoto N, Ohta Y, Ikeda Y, Abe K (2012) Statins have therapeutic potential for the treatment of Alzheimer's disease, likely via protection of the neurovascular unit in the AD brain. J Neurol Sci 322, 59-63.
28. Pac-Soo C, Lloyd DG, Vizcaychipi MP, Ma D (2011) Statins: The role in the treatment and prevention of Alzheimer's neu-rodegeneration. J Alzheimers Dis 27, 1-10.
29. Frisardi V, Panza F, Seripa D, Farooqui T, Farooqui AA (2011) Glycerophospholipids and glycerophospholipid-derived lipid mediators: A complex meshwork in Alzheimer's disease pathology. Prog Lipid Res 50, 313-330.
30. Fraser T, Tayler H, Love S (2010) Fatty acid composition of frontal, temporal and parietal neocortex in the normal human brain and in Alzheimer's disease. Neurochem Res 35, 503-513.
31. Amtul Z, Westaway D, Cechetto DF, Rozmahel RF (2011) Oleic acid ameliorates amyloidosis in cellular and mouse models of Alzheimer's disease. Brain Pathol 21, 321-329.
32. Nakamura S (1992) [Amino acid metabolism in neurodegen-erative diseases]. Nihon Rinsho 50, 1637-1642.
33. Sun N, Hartmann R, Lecher J, Stoldt M, Funke SA, Gremer L, Ludwig HH, Demuth HU, Kleinschmidt M, Willbold D (2012) Structural analysis of the pyroglutamate-modified iso-form of the Alzheimer's disease-related amyloid-beta using NMR spectroscopy. J Pept Sci 18, 691-695.
34. Gueli MC, Taibi G (2013) Alzheimer's disease: Amino acid levels and brain metabolic status. Neurol Sci 34, 1575-1579.
35. Trushina E, Mielke MM (2013) Recent advances in the application of metabolomics to Alzheimer's disease. Biochim Biophys Acta, doi: 10.1016/j.bbadis.2013.06.014
36. Marjanska M, Curran GL, Wengenack TM, Henry PG, Bliss RL, Poduslo JF, Jack CR, Jr., Ugurbil K, Garwood M (2005) Monitoring disease progression in transgenic mouse models of Alzheimer's disease with proton magnetic resonance spectroscopy. Proc Natl Acad Sci USA 102, 11906-11910.
37. Oberg J, Spenger C, Wang FH, Andersson A, Westman E, Skoglund P, Sunnemark D, Norinder U, Klason T, Wahlund LO, Lindberg M (2008) Age related changes in brain metabolites observed by 1H MRS in APP/PS1 mice. Neurobiol Aging 29, 1423-1433.
38. Oresic M, Hyotylainen T, Herukka SK, Sysi-Aho M, Mat-tila I, Seppanan-Laakso T, Julkunen V, Gopalacharyulu PV, Hallikainen M, Koikkalainen J, Kivipelto M, Helisalmi S, Lotjonen J, Soininen H (2011) Metabolome in progression to Alzheimer's disease. Transl Psychiatry 1, e57.